Opthotech Raises $36 Million

Opthotech Corp., a Princeton, N.J.-based drug company focused on back-of-the-eye diseases, has raised $36 million in Series A funding. SV Life Sciences led the deal, and was joined by HBM BioVentures and Novo AS.